Search
for
Sort by
Research 511–540 of 1000+
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- The Dickkopf Protein Family in Non-Neoplastic Disorders: Emerging Roles and Therapeutic Targeting
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Assessing medication use patterns among patients with polycystic ovary syndrome at a tertiary care teaching hospital in South Korea: A retrospective study
- From Hair Loss to Vision Loss: Minoxidil-Associated CRVO in a Young Female
- Innovative Reports on the Effects of Anabolic Androgenic Steroid Abuse—How to Lose Your Mind for the Love of Sport
- Reconnecting
- Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
- Antioxidant Activities of Natural Polysaccharides and Their Derivatives for Biomedical and Medicinal Applications
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Systemic Lupus Erythematosus
- Association between Alopecia Areata, Psoriasis Vulgaris, Thyroid Disease, and Metabolic Syndrome
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Endoplasmic reticulum in health and disease: the 12th International Calreticulin Workshop, Delphi, Greece
- Metabolic syndrome — a new definition and management guidelines
- Exploring the application of dietary antioxidant index for disease risk assessment: a comprehensive review
- Is Dihydrotestosterone a Classic Hormone?
- The role of mutations on gene AR, in androgenetic alopecia syndrome
- Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
- Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
- Targeting integrin pathways: mechanisms and advances in therapy
- Peripheral Arterial Disease: Diagnosis and Management
- New oral anticoagulants and their reversal agents
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Guidelines for the prevention of lower extremity arterial ulcers
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Affirmation as Male
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial